Trial Profile
A Study Assessing the Effectiveness, Safety and Economic Rationality of the Neoadjuvant Chemotherapy with Biosimilar of Trastuzumab in HER2+ Breast Cancer in Russian Clinical Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jun 2018
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary) ; Anthracyclines; Carboplatin; Taxanes
- Indications Advanced breast cancer; Early breast cancer
- Focus Adverse reactions; Therapeutic Use
- 12 Jun 2018 New trial record
- 05 Jun 2018 Results presented at the 54th Annual Meeting of the American Society of Clinical Oncology.